A detailed history of Mount Lucas Management LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Mount Lucas Management LP holds 13,598 shares of EXEL stock, worth $545,143. This represents 0.27% of its overall portfolio holdings.

Number of Shares
13,598
Holding current value
$545,143
% of portfolio
0.27%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$34.13 - $46.26 $464,099 - $629,043
13,598 New
13,598 $599,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $12.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Mount Lucas Management LP Portfolio

Follow Mount Lucas Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Lucas Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Mount Lucas Management LP with notifications on news.